- 全部删除
- 您的购物车当前为空
GSK-3β inhibitor 14 (1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-) 是一种较弱的 GSK-3β 抑制剂,IC50﹥ 100μM。
为众多的药物研发团队赋能,
让新药发现更简单!
GSK-3β inhibitor 14 (1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-) 是一种较弱的 GSK-3β 抑制剂,IC50﹥ 100μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 347 | In stock | |
5 mg | ¥ 861 | In stock | |
10 mg | ¥ 1,270 | In stock | |
25 mg | ¥ 2,070 | In stock | |
50 mg | ¥ 3,100 | In stock | |
100 mg | ¥ 4,130 | In stock | |
200 mg | ¥ 5,590 | In stock |
GSK-3β inhibitor 14 相关产品
产品描述 | GSK-3β inhibitor 14 (1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-) is a weak GSK-3β inhibitor, IC50﹥ 100μM. |
靶点活性 | GSK-3β:﹥ 100μM |
别名 | 1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)- |
分子量 | 283.39 |
分子式 | C17H17NOS |
CAS No. | 863004-48-2 |
Smiles | C(N1C=2C(SC(C)CC1=O)=CC=CC2)C3=CC=CC=C3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||
溶解度信息 | DMSO: 2.7 mg/mL (9.53 mM), Sonication is recommended. | |||||||||||||||
溶液配制表 | ||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容